2019 -
2022 Vice President, Translational Medicine @
2018 -
2019 Director of Translational Medicine @
2014 -
2018 Head of Biomarkers @
2012 -
2014 Head of Drug Discovery, Science Funding Dept @
2004 -
2012 Group and Project Leader, Biology @ Chroma Therapeutics
2000 -
2003 Team Leader, Gene Discovery @
1994 -
2000 Senior Scientist @ British Biotech
1990 -
1994 PhD @ Royal Free Hospital, University of London
David Krige Education
Royal Free Hospital, University of London
PhD (Biochemistry)
1990
-
1994
UCL
MSc (Applied Molecular Biology and Biotechnology; distinction)
1988
-
1989
Queen Mary University of London
BSc (Genetics)
1985
-
1988
David Krige Skills
Molecular Biology
Biochemistry
Genomics
Cell Based Assays
Drug Discovery
Oncology
Cell Biology
Customer Service
Biomarkers
Research
Data Analysis
David Krige Summary
David Krige, based in Oxford, GB, is currently a Chief Development Officer (CDO) at Accession Therapeutics Limited. David Krige brings experience from previous roles at Accession Therapeutics Limited, PsiOxus Therapeutics Ltd and Immunocore. David Krige holds a 1990 - 1994 PhD in Biochemistry @ Royal Free Hospital, University of London. With a robust skill set that includes Molecular Biology, Biochemistry, Genomics, Cell Based Assays, Drug Discovery and more. David Krige has 1 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.